Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX302 in localised prostate cancer
NCT02499848Phase 2Completed
- Sponsor
- Sophiris Bio Inc.
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of topsalysin in prostate cancer (PCa), sponsored by Sophiris Bio Inc.. Started Jul 2015; status: completed.
02
Drugs
topsalysin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02499848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499848.